148 related articles for article (PubMed ID: 23098298)
1. Evaluation of the asparagine synthetase level in leukemia cells by monoclonal antibodies.
Kusano-Arai O; Iwanari H; Mochizuki Y; Nakata H; Kodama T; Kitoh T; Hamakubo T
Hybridoma (Larchmt); 2012 Oct; 31(5):325-32. PubMed ID: 23098298
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of anti-ASNS monoclonal antibody and detection of ASNS expression in tumor].
Shi W; Zhang QY; Jia ZS; Xu JJ; Wang YM; Yong WB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):74-7. PubMed ID: 21208570
[TBL] [Abstract][Full Text] [Related]
3. Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines.
Su N; Pan YX; Zhou M; Harvey RC; Hunger SP; Kilberg MS
Pediatr Blood Cancer; 2008 Feb; 50(2):274-9. PubMed ID: 17514734
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients.
Abbatiello SE; Pan YX; Zhou M; Wayne AS; Veenstra TD; Hunger SP; Kilberg MS; Eyler JR; Richards NG; Conrads TP
J Proteomics; 2008 Apr; 71(1):61-70. PubMed ID: 18541474
[TBL] [Abstract][Full Text] [Related]
5. Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.
Hermanova I; Zaliova M; Trka J; Starkova J
Exp Hematol; 2012 Aug; 40(8):657-65. PubMed ID: 22542578
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells.
Krejci O; Starkova J; Otova B; Madzo J; Kalinova M; Hrusak O; Trka J
Leukemia; 2004 Mar; 18(3):434-41. PubMed ID: 14724653
[TBL] [Abstract][Full Text] [Related]
7. Tumoral microenvironment prevents de novo asparagine biosynthesis in B cell lymphoma, regardless of ASNS expression.
Grima-Reyes M; Vandenberghe A; Nemazanyy I; Meola P; Paul R; Reverso-Meinietti J; Martinez-Turtos A; Nottet N; Chan WK; Lorenzi PL; Marchetti S; Ricci JE; Chiche J
Sci Adv; 2022 Jul; 8(27):eabn6491. PubMed ID: 35857457
[TBL] [Abstract][Full Text] [Related]
8. Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.
Aslanian AM; Fletcher BS; Kilberg MS
Biochem J; 2001 Jul; 357(Pt 1):321-8. PubMed ID: 11415466
[TBL] [Abstract][Full Text] [Related]
9. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.
Aslanian AM; Kilberg MS
Biochem J; 2001 Aug; 358(Pt 1):59-67. PubMed ID: 11485552
[TBL] [Abstract][Full Text] [Related]
10. Glutaminase Activity of L-Asparaginase Contributes to Durable Preclinical Activity against Acute Lymphoblastic Leukemia.
Chan WK; Horvath TD; Tan L; Link T; Harutyunyan KG; Pontikos MA; Anishkin A; Du D; Martin LA; Yin E; Rempe SB; Sukharev S; Konopleva M; Weinstein JN; Lorenzi PL
Mol Cancer Ther; 2019 Sep; 18(9):1587-1592. PubMed ID: 31209181
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between asparagine synthetase expression level and cell sensitivity to L-asparaginase in human leukemic cell lines].
Li BS; He YY; Luo CY; Jiang H; Shen SH; Jiang LM; Zhang B; Gu LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):559-63. PubMed ID: 20561401
[TBL] [Abstract][Full Text] [Related]
12. [Asparagine synthetase activity in pediatric acute lymphoblastic leukemia].
Jiang H; Gu LJ; Xue HL; Tang JY; Chen J; Pan C; Chen J
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):272-4. PubMed ID: 16923354
[TBL] [Abstract][Full Text] [Related]
13. Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia.
Dimitriou H; Choulaki C; Perdikogianni C; Stiakaki E; Kalmanti M
Int J Hematol; 2014 Mar; 99(3):305-10. PubMed ID: 24474640
[TBL] [Abstract][Full Text] [Related]
14. Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines.
Chien WW; Le Beux C; Rachinel N; Julien M; Lacroix CE; Allas S; Sahakian P; Cornut-Thibaut A; Lionnard L; Kucharczak J; Aouacheria A; Abribat T; Salles G
Sci Rep; 2015 Jan; 5():8068. PubMed ID: 25626693
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of asparaginase pathway and asparaginase-related complications in children with acute lymphoblastic leukemia.
Ben Tanfous M; Sharif-Askari B; Ceppi F; Laaribi H; Gagné V; Rousseau J; Labuda M; Silverman LB; Sallan SE; Neuberg D; Kutok JL; Sinnett D; Laverdière C; Krajinovic M
Clin Cancer Res; 2015 Jan; 21(2):329-34. PubMed ID: 24907114
[TBL] [Abstract][Full Text] [Related]
16. Utility of
Watanabe A; Miyake K; Yamada Y; Sunamura EI; Yotani T; Kagami K; Kasai S; Tamai M; Harama D; Akahane K; Goi K; Sakaguchi K; Goto H; Kitahara S; Inukai T
Epigenetics; 2023 Dec; 18(1):2268814. PubMed ID: 37839090
[TBL] [Abstract][Full Text] [Related]
17. A sulfoximine-based inhibitor of human asparagine synthetase kills L-asparaginase-resistant leukemia cells.
Ikeuchi H; Ahn YM; Otokawa T; Watanabe B; Hegazy L; Hiratake J; Richards NG
Bioorg Med Chem; 2012 Oct; 20(19):5915-27. PubMed ID: 22951255
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.
Iwamoto S; Mihara K; Downing JR; Pui CH; Campana D
J Clin Invest; 2007 Apr; 117(4):1049-57. PubMed ID: 17380207
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of GCN2 sensitizes ASNS-low cancer cells to asparaginase by disrupting the amino acid response.
Nakamura A; Nambu T; Ebara S; Hasegawa Y; Toyoshima K; Tsuchiya Y; Tomita D; Fujimoto J; Kurasawa O; Takahara C; Ando A; Nishigaki R; Satomi Y; Hata A; Hara T
Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7776-E7785. PubMed ID: 30061420
[TBL] [Abstract][Full Text] [Related]
20. Asparagine synthetase chemotherapy.
Richards NG; Kilberg MS
Annu Rev Biochem; 2006; 75():629-54. PubMed ID: 16756505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
